Results 11 to 20 of about 38,964 (184)

Xanthine oxidoreductase and xanthine oxidase in human cornea. [PDF]

open access: yesHistology and histopathology, 2002
Xanthine oxidoreductase (xanthine dehydrogenase + xanthine oxidase) is a complex enzyme that catalyzes the oxidation of hypoxanthine to xanthine, subsequently producing uric acid. The enzyme complex exists in separate but interconvertible forms, xanthine dehydrogenase and xanthine oxidase, which generate reactive oxygen species (ROS), a well known ...
Cejkova, J.   +3 more
openaire   +4 more sources

The Thermodynamics of Xanthine Oxidoreductase Catalysis [PDF]

open access: yesAntioxidants & Redox Signaling, 1999
Xanthine oxidoreductase is a complex enzyme found in a wide range of organisms. Recent interest in this enzyme stems from its ability to produce reactive oxygen species under a range of conditions. It is found as a homodimer, each unit containing a molybdopterin cofactor, two iron sulfur centers, and FAD.
Sanders, Stephen A., Massey, Vincent
openaire   +5 more sources

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase [PDF]

open access: yesRedox Biology, 2019
Obesity and related pathologies such as diabetes and metabolic syndrome are associated with chronic inflammation and cancer. The serum level of xanthine oxidoreductase (XOR) is correlated to obesity-associated metabolic disorders.
Maria Giulia Battelli   +3 more
doaj   +2 more sources

Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease [PDF]

open access: yesAntioxidants
Xanthine Oxidoreductase (XOR) is a ubiquitous, essential enzyme responsible for the terminal steps of purine catabolism, ultimately producing uric acid that is eliminated by the kidneys.
Hunter W. Korsmo   +2 more
doaj   +2 more sources

Mechanism of porcine liver xanthine oxidoreductase mediated N-oxide reduction of cyadox as revealed by docking and mutagenesis studies. [PDF]

open access: yesPLoS ONE, 2013
Xanthine oxidoreductase (XOR) is a cytoplasmic molybdenum-containing oxidoreductase, catalyzing both endogenous purines and exogenous compounds. It is suggested that XOR in porcine hepatocytes catalyzes the N-oxide reduction of quinoxaline 1,4-di-N ...
Chigang Chen   +7 more
doaj   +2 more sources

Inhibition of xanthine oxidoreductase with febuxostat, but not allopurinol, prevents inflammasome assembly and IL-1β release [PDF]

open access: yesLife Science Alliance
This study focuses on the underappreciated distinct effects of two clinically used xanthine oxidoreductase inhibitors: allopurinol and febuxostat. Besides reducing uric acid levels in gout treatment, febuxostat, but not allopurinol, prevents NLRP3 ...
Lauar de Brito Monteiro   +9 more
doaj   +2 more sources

The nitrite reductase activity of xanthine oxidoreductase sustains cardiovascular health as mice age [PDF]

open access: yesRedox Biology
Background: Xanthine oxidoreductase (XOR) is a multi-functional enzyme that metabolises purines generating uric acid and generates reactive oxygen species. Both functions have been implicated in the pathogenesis of cardiovascular disease.
Nicki Dyson   +14 more
doaj   +2 more sources

Xanthine oxidoreductase in cancer: more than a differentiation marker [PDF]

open access: yesCancer Medicine, 2015
AbstractHuman xanthine oxidoreductase (XOR) catalyzes the last two steps of purine catabolism and is present in two interconvertible forms, which may utilize O2 or NAD+ as electron acceptors. In addition to uric acid, XOR products may comprise reactive oxygen and nitrogen species that have many biologic effects, including inflammation, endothelial ...
BATTELLI, MARIA GIULIA   +3 more
openaire   +5 more sources

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy [PDF]

open access: yesFEBS Open Bio, 2021
Xanthine oxidoreductase (XOR) is a critical enzyme in purine metabolism and uric acid production, and its levels are reported to increase during stress, thereby promoting organ damage.
Takeo Ishii   +13 more
doaj   +2 more sources

Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression [PDF]

open access: yesFrontiers in Immunology, 2022
ObjectiveLimiting purine intake, inhibiting xanthine oxidoreductase (XOR) and inhibiting urate reabsorption in proximal tubule by uricosuric drugs, to reduce serum uric acid (UA) levels, are recognized treatments for gout.
Huanhuan Wang   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy